NASDAQ:AMTX - Aemetis Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$0.87 -0.03 (-3.33 %)
(As of 03/19/2019 04:00 PM ET)
Previous Close$0.90
Today's Range$0.86 - $0.90
52-Week Range$0.42 - $2.49
Volume11,900 shs
Average Volume71,145 shs
Market Capitalization$17.70 million
P/E RatioN/A
Dividend YieldN/A
Beta0.71
Aemetis, Inc. operates as a renewable fuels and bio-chemicals company in North America and India. The company focuses on the acquisition, development, and commercialization of various technologies that replace traditional petroleum-based products by the conversion of ethanol and biodiesel plants into advanced bio refineries. It owns and operates an ethanol plant in the California Central Valley near Modesto; and a biodiesel plant in Kakinada, India. The company sells biodiesel and refined glycerin to resellers, distributors, and refiners through its sales force and independent sales agents, as well as to brokers who resell the product to end-users. It also produces ethanol; and wet distiller's grains, distiller's corn oil, and condensed distillers soluble or corn syrup products to dairies and feedlots as animal feed. The company was formerly known as AE Biofuels, Inc. and changed its name to Aemetis, Inc. in November 2011. Aemetis, Inc. was founded in 2005 and is headquartered in Cupertino, California.

Receive AMTX News and Ratings via Email

Sign-up to receive the latest news and ratings for AMTX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Industrial organic chemicals
Sub-IndustryN/A
SectorOils/Energy
Current SymbolNASDAQ:AMTX
CUSIPN/A
Phone408-517-3304

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$150.15 million
Book Value($4.03) per share

Profitability

Net Income$-30,300,000.00

Miscellaneous

EmployeesN/A
Market Cap$17.70 million
Next Earnings DateN/A
OptionableNot Optionable

Aemetis (NASDAQ:AMTX) Frequently Asked Questions

What is Aemetis' stock symbol?

Aemetis trades on the NASDAQ under the ticker symbol "AMTX."

How were Aemetis' earnings last quarter?

Aemetis Inc (NASDAQ:AMTX) released its quarterly earnings results on Monday, November, 14th. The specialty chemicals company reported ($0.21) EPS for the quarter, beating analysts' consensus estimates of ($0.27) by $0.06. The specialty chemicals company had revenue of $39.38 million for the quarter, compared to analysts' expectations of $37.75 million. View Aemetis' Earnings History.

What price target have analysts set for AMTX?

1 equities research analysts have issued 1-year target prices for Aemetis' shares. Their predictions range from $2.00 to $2.00. On average, they expect Aemetis' stock price to reach $2.00 in the next year. This suggests a possible upside of 129.9% from the stock's current price. View Analyst Price Targets for Aemetis.

What is the consensus analysts' recommendation for Aemetis?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Aemetis in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Aemetis.

Has Aemetis been receiving favorable news coverage?

News stories about AMTX stock have been trending somewhat negative this week, InfoTrie reports. InfoTrie rates the sentiment of news coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Aemetis earned a daily sentiment score of -1.9 on InfoTrie's scale. They also gave media coverage about the specialty chemicals company a news buzz of 8.0 out of 10, meaning that recent news coverage is very likely to have an effect on the stock's share price in the next few days.

Who are some of Aemetis' key competitors?

What other stocks do shareholders of Aemetis own?

Who are Aemetis' key executives?

Aemetis' management team includes the folowing people:
  • Mr. Eric A. McAfee, Co-Founder, Exec. Chairman, CEO & Pres (Age 56)
  • Mr. Todd A. Waltz, Exec. VP, CFO & Sec. (Age 58)
  • Mr. Andrew B. Foster, Exec. VP & COO (Age 54)
  • Mr. Sanjeev Gupta, Exec. VP & MD, Chairman and Pres of Universal Biofuels Pvt. Ltd. (Age 59)

Who are Aemetis' major shareholders?

Aemetis' stock is owned by many different of retail and institutional investors. Top institutional investors include CIBC Private Wealth Group LLC (6.06%). View Institutional Ownership Trends for Aemetis.

Which major investors are selling Aemetis stock?

AMTX stock was sold by a variety of institutional investors in the last quarter, including CIBC Private Wealth Group LLC. View Insider Buying and Selling for Aemetis.

How do I buy shares of Aemetis?

Shares of AMTX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Aemetis' stock price today?

One share of AMTX stock can currently be purchased for approximately $0.87.

How big of a company is Aemetis?

Aemetis has a market capitalization of $17.70 million and generates $150.15 million in revenue each year.

What is Aemetis' official website?

The official website for Aemetis is http://www.aemetis.com.

How can I contact Aemetis?

Aemetis' mailing address is 20400 STEVENS CREEK BLVD SUITE 700, CUPERTINO CA, 95014. The specialty chemicals company can be reached via phone at 408-517-3304 or via email at [email protected]


MarketBeat Community Rating for Aemetis (NASDAQ AMTX)

Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  99 (Vote Outperform)
Underperform Votes:  139 (Vote Underperform)
Total Votes:  238
MarketBeat's community ratings are surveys of what our community members think about Aemetis and other stocks. Vote "Outperform" if you believe AMTX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AMTX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 3/19/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel